Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Murray Barclay

Showing results (11-20 of 38) with videos related to

Pageof 4
Sort By:
Inflammatory Bowel Diseases|February 21, 2018
Combination Immunosuppression in IBDSteven Bots, Krisztina Gecse, Murray Barclay, et al.
The New Zealand Medical Journal|January 31, 2004
Digoxin therapeutic drug monitoring: an audit and reviewAndrew Sidwell, Murray Barclay, Evan Begg, et al.
The New Zealand Medical Journal|August 5, 2003
6-thioguanine nucleotides and thiopurine methyltransferase activity: important factors determining response to treatment and incidence of adverse effects from azathioprine and 6-MPRichard Gearry, Murray Barclay, Sharon Gardiner, et al.
The New Zealand Medical Journal|May 12, 2005
Faecal calprotectin: the case for a novel non-invasive way of assessing intestinal inflammationRichard Gearry, Murray Barclay, Christopher Florkowski, et al.
Archives of Physical Medicine and Rehabilitation|November 8, 2005
Submental surface electromyographic measurement and pharyngeal pressures during normal and effortful swallowingMaggie-Lee Huckabee, Susan G Butler, Murray Barclay, et al.
Therapeutic Drug Monitoring|January 28, 2003
Lack of clinically significant interference by spironolactone with the AxSym Digoxin II assayGrant Howard, Murray Barclay, Chris Florkowski, et al.
International Journal of Rheumatic Diseases|September 3, 2024
The prevalence and clinical features of leflunomide-associated peripheral neuropathy in patients with rheumatic disease in a New Zealand cohortGursimran Kaur, Murray Barclay, Joanne Mitchell, et al.
Bjpsych Open|March 13, 2025
A clinical decision support alert to promote timely laxative use in in-patients prescribed clozapineMilan Sundermann, Susanna Every-Palmer, Murray Barclay, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|October 31, 2006
The use of low dose methotrexate in rheumatoid arthritis - are we entering a new era of therapeutic drug monitoring and pharmacogenomics?Lisa Stamp, Rebecca Roberts, Martin Kennedy, et al.
BMJ Open|November 25, 2016
Burnout prevalence in New Zealand's public hospital senior medical workforce: a cross-sectional mixed methods studyCharlotte N L Chambers, Christopher M A Frampton, Murray Barclay, et al.
Pageof 4

Showing results (11-20 of 38) with videos related to

Sort By:
Pageof 4
Inflammatory Bowel Diseases|February 21, 2018
Combination Immunosuppression in IBDSteven Bots, Krisztina Gecse, Murray Barclay, et al.
The New Zealand Medical Journal|January 31, 2004
Digoxin therapeutic drug monitoring: an audit and reviewAndrew Sidwell, Murray Barclay, Evan Begg, et al.
The New Zealand Medical Journal|August 5, 2003
6-thioguanine nucleotides and thiopurine methyltransferase activity: important factors determining response to treatment and incidence of adverse effects from azathioprine and 6-MPRichard Gearry, Murray Barclay, Sharon Gardiner, et al.
The New Zealand Medical Journal|May 12, 2005
Faecal calprotectin: the case for a novel non-invasive way of assessing intestinal inflammationRichard Gearry, Murray Barclay, Christopher Florkowski, et al.
Archives of Physical Medicine and Rehabilitation|November 8, 2005
Submental surface electromyographic measurement and pharyngeal pressures during normal and effortful swallowingMaggie-Lee Huckabee, Susan G Butler, Murray Barclay, et al.
Therapeutic Drug Monitoring|January 28, 2003
Lack of clinically significant interference by spironolactone with the AxSym Digoxin II assayGrant Howard, Murray Barclay, Chris Florkowski, et al.
International Journal of Rheumatic Diseases|September 3, 2024
The prevalence and clinical features of leflunomide-associated peripheral neuropathy in patients with rheumatic disease in a New Zealand cohortGursimran Kaur, Murray Barclay, Joanne Mitchell, et al.
Bjpsych Open|March 13, 2025
A clinical decision support alert to promote timely laxative use in in-patients prescribed clozapineMilan Sundermann, Susanna Every-Palmer, Murray Barclay, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|October 31, 2006
The use of low dose methotrexate in rheumatoid arthritis - are we entering a new era of therapeutic drug monitoring and pharmacogenomics?Lisa Stamp, Rebecca Roberts, Martin Kennedy, et al.
BMJ Open|November 25, 2016
Burnout prevalence in New Zealand's public hospital senior medical workforce: a cross-sectional mixed methods studyCharlotte N L Chambers, Christopher M A Frampton, Murray Barclay, et al.
Pageof 4